University Hospital, Montpellier
1,318
158
173
681
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.0%
158 terminated/withdrawn out of 1318 trials
81.2%
-5.3% vs industry average
3%
43 trials in Phase 3/4
0%
2 of 681 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1318)
ST2 for the Management of Heart Failure - STADE-HF
Role: lead
Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2
Role: lead
SvO2 Trigger in Transfusion Strategy After Cardiac Surgery
Role: lead
Breakpoint Analysis of de Novo Apparently Balanced Chromosomal Translocations
Role: lead
Modeling Spinal Mobility in Ankylosing Spondylitis: Towards New Telekinetic Biomarkers
Role: lead
Medico-economic Evaluation of a Project of Wounds by a Remote Network
Role: lead
COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer
Role: lead
Muscle Training Induced Angiogenesis in COPD
Role: lead
Therapeutic Orientation Test in Thrombotic Microangiopathy
Role: lead
COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction
Role: lead
Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure
Role: lead
TAVI Without Balloon Predilatation (of the Aortic Valve ) SAPIEN 3
Role: lead
Identification of Non-motor Brain Areas Involved in Upper Limb Motor Recovery After Stroke
Role: lead
Controlled Trial Evaluating the Efficacy of Protein Supplementation in the Short Term After Bariatric Surgery
Role: lead
Pectoral Nerve Block for Analgesia After Breast Augmentation
Role: lead
Standard Patient Training Versus Vik Chatbot Guided Training: a Randomized Controlled Trial for Asthma Patients
Role: lead
NIPD of CFTC by WGA Coupled to Mini-exome Sequencing
Role: lead
Drug Provocation Test (DPT) to Paracetamol
Role: lead
Evaluation and Validation of Management Strategy for Conductive Disorders After TAVR (EVATAVI)
Role: lead
Transition From Adolescents to Adulthood for Patients With Congenital Heart Diseases
Role: lead